ClinicalTrials.gov
public full text
Public Domain
Real-world Health Outcomes in Canadian Patients Using Semaglutide
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program#843294
- A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range#894938
- Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity#835560
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight#1031259
- Higher semaglutide dose is associated with lower neuropsychiatric event incidence independent of weight loss#684656
Record · ID 407860
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive